Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

fresenius kabi malaysia sdn. bhd - fluconazole -

Singapore - English - HSA (Health Sciences Authority)

fresenius medical care singapore pte. ltd. - gastroenterology & urology - fresenius multifiltrate kit is for continuous renal replacement therapy. ultraflux av 600s and av1000s are designed for single use in acute dialysis with machine assisted continuous veno-venous haemofiltration, haemodialysis and haemodiafiltration (cvvh, cvvhd, cvvhdf). av600s is also suitable for a non-machine assisted continuous arterio-venous haemofiltration or haemodialysis (cavh, cavhd). av1000s is specifically recommended for high volume cvvh/cvvhdf. ultraflux emic2 are designed for single use in acute dialysis with machine assisted continuous veno-venous haemodialysis (cvvhd) as well as for the sledd- therapy (slow extended daily dialysis). blood line/ tubing systems (cassette multifiltrate, cassette cica multifiltrate, dialysate system multifiltrate) are intended for single use only for extracorporeal blood purification.

Singapore - English - HSA (Health Sciences Authority)

fresenius medical care singapore pte. ltd. - gastroenterology & urology - fresenius multifiltrate kit 5 pre post cvvh 600 is for continuous renal replacement therapy . ultraflux av 600s are designed for single use in acute dialysis with machine assisted continuous veno-venous haemofiltration, haemodialysis and haemodiafiltration (cvvh, cvvhd, cvvhdf). it is also suitable for a non-machine assisted conditions arterio-venous haemofiltration or haemodialysis (cavh, cavhd). multifiltrate cassette and dialysate hv-cvvh substituate set are intended for single use only for extracorporeal blood purification. for use with multifiltrate acute dialysis machines.

Singapore - English - HSA (Health Sciences Authority)

fresenius medical care singapore pte. ltd. - general hospital - fresenius blood lines, tubing systems, and accessories are intended for use in the extracorporeal purification of blood in the framework of renal replacement therapy.

Singapore - English - HSA (Health Sciences Authority)

fresenius medical care singapore pte. ltd. - general hospital - fresenius blood lines, tubing systems, and accessories are intended for use in the extracorporeal purification of blood in the framework of renal replacement therapy.

Singapore - English - HSA (Health Sciences Authority)

fresenius kabi (singapore) pte ltd - general hospital - fresenius extension asv y bcv syringe pump infusion line is single use connecting lines for extension of infusion and transfusion sets, for use with pressure infusion equipment.

Singapore - English - HSA (Health Sciences Authority)

fresenius medical care singapore pte. ltd. - general hospital - fresenius blood lines, tubing systems, and accessories are intended for use in the extracorporeal purification of blood in the framework of renal replacement therapy.

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - propofol (unii: yi7vu623sf) (propofol - unii:yi7vu623sf) - the u.s. food and drug administration (fda) has issued an emergency use authorization (eua) to permit the emergency use of the unapproved product, fresenius propoven 2% (propofol 20 mg/ml) emulsion 100 ml, to maintain sedation via continuous infusion in patients greater than 16 years old who require mechanical ventilation in an intensive care unit (icu) setting. caution: there is a risk of unintentional overdose with this unapproved product. fresenius propoven 2% emulsion contains the same active ingredient, propofol, as fda-approved diprivan injectable emulsion usp 10 mg/ml, but contains double the concentration. because of this difference in concentration between this unapproved product and the fda-approved product, there is a risk of unintentional overdose. fresenius propoven 2% emulsion 100ml is not an fda-approved drug in the united states. however, fda has issued an eua permitting the emergency use of fresenius propoven 2% emulsion during the covid-19 pandemic. the scope of the eua is limited as follows

United States - English - NLM (National Library of Medicine)

fresenius kabi austria gmbh - propofol (unii: yi7vu623sf) (propofol - unii:yi7vu623sf) - the u.s. food and drug administration (fda) has issued an emergency use authorization (eua) to permit the emergency use of the unapproved product, fresenius propoven 2% (propofol 20 mg/ml) emulsion 100 ml, to maintain sedation via continuous infusion in patients greater than 16 years old who require mechanical ventilation in an intensive care unit (icu) setting. caution: there is a risk of unintentional overdose with this unapproved product. fresenius propoven 2% emulsion contains the same active ingredient, propofol, as fda-approved diprivan injectable emulsion usp 10 mg/ml, but contains double the concentration. because of this difference in concentration between this unapproved product and the fda-approved product, there is a risk of unintentional overdose. fresenius propoven 2% emulsion 100ml is not an fda-approved drug in the united states. however, fda has issued an eua permitting the emergency use of fresenius propoven 2% emulsion during the covid-19 pandemic. the scope of the eua is limited as follows

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius medical care australia pty ltd - 11226 - dialyser, peritoneal unit - to treat renal failure by removing fluid and metabolic wastes from the blood by peritoneal dialysis.